MEDICINES
PATIENT ASSISTANCE PROGRAMS
IMPORTED MEDICINES
CONTACT US
UploadHome > BERACTANT
Beractant
This page contains brief details about the drug beractant, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
The U.S. FDA approved Beractant for pulmonary disorders on March 7, 1991. Beractant belong to the medication class known as pulmonary surfactants. It is extracted from cow’s lungs to help the children breathe.
Mechanism of Action of Beractant
Beractant works by providing a substance called surfactant to the baby’s lungs. This surfactant helps the lungs work better by reducing the tension on the surfaces of the air sacs. It also helps keep the air sacs open and prevents them from collapsing during breathing. This makes it easier for the baby to breathe and improves their lung function.
Uses of Beractant
Beractant is employed to prevent and manage Respiratory Distress Syndrome (RDS) in premature infants weighing 700g or more at birth. Additionally, it is administered to premature babies born before 32 weeks of gestation who are at risk of RDS and require endotracheal intubation for stabilization. RDS is characterized by underdeveloped lungs in premature infants, resulting in respiratory challenges.
Beractant Drug administaration and Dosage available
Beractant requires administration by a qualified medical professional. It should be delivered through the endotracheopulmonary route, with a dose administered via a tube or catheter inserted into the windpipe. The appropriate dosage and duration will be determined by your physician considering factors such as age, body weight, and medical condition. It is crucial not to self-administer this medication.
Warnings, Precautions and Side Effects of Beractant
Warnings
Beractant should not be consumed if you are allergic to Beractant or any of its ingredients in the medication. Seek immediate medical attention if you experience serious eye symptoms, heart issues, or severe neurological symptoms while using this medication. Consult your healthcare provider for any concerns or allergies.
Precautions
Beractant should only be administered in a closely monitored clinical setting by an experienced physician familiar with premature infant care. Monitoring of oxygen and carbon dioxide levels is essential during treatment. If bradycardia or decreased oxygen saturation occurs during dosing, the procedure should be paused, and appropriate measures are taken.
Side Effects
The most common side effects of Beractant are noisy breathing, feeding or bowel problems, and bleeding around the endotracheal tube.
Word Of Advice
Beractant is not intended for the pregnant and breastfeeding women. Notify your doctor if your baby experiences any serious side effects. Contact your doctor for more information. Store the medicine at 2°C to 8°C.
Frequently Asked Question
Beractant is not indicated for women of childbearing age and should not be used during pregnancy. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of the medication with your healthcare provider.
Beractant is a type of medication that belongs to pulmonary surfactants, which is extracted from cow’s lungs to help the children breathe. This medication prevents and treats Respiratory Distress Syndrome (RDS) in premature newborns.
Beractant is administered directly into the baby’s windpipe through a tube or catheter. This procedure is usually performed in a highly supervised clinical setting by experienced medical professionals.
Beractant is considered safe and effective when used as prescribed by healthcare providers for the treatment of RDS. Clinical studies have shown positive outcomes in improving lung function and aiding breathing in premature infants.
Disclaimer
The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.